The 2021 EU4Health work programme focuses on crisis preparedness, disease prevention, stronger health systems and healthcare workforce and digital, with cancer as a cross-cutting priority.
Following the adoption of the EU Therapeutics Strategy, the European Commission is organising an EU matchmaking event on COVID-19 therapeutics on 12-13 July 2021.
Deadline extended to 1 July 2021.
As of today, EU4Health will fund more modern and resilient health systems, interventions to shore up our preparedness against health crises and more decisive EU action in the fight against cancer.
Today, the European Commission is presenting a Communication on the early lessons learnt from the COVID-19 pandemic over the past 18 months and building on them to improve action at EU and national level.
The main purpose of the scientific opinion is to support the Commission by reviewing two reports related to the use of squishy toys published by the Danish Environmental Protection Agency (EPA) and the Swedish Chemical Agency (KEMI).
Today, the EU Digital COVID Certificate has reached another important milestone with the go-live of the technical system at EU level, which allows to verify certificates in a secure and privacy-friendly way.
As of today, the Regulation on medical devices (MDR) is fully applicable, after a one year postponement due to the COVID-19 pandemic.
The report examines the progress achieved so far: the Directive contributed to the reduction of tobacco consumption and generated positive outcomes for public health.
The Health Security Committee (HSC) has agreed to update the common list of COVID-19 rapid antigen tests (RATs), including those whose results are mutually recognised by EU Member States for public health measures.
Interested parties are invited to share their views via a questionnaire, until 30 July, to help explore several options in view of the revision of the legislation.